Ontology type: schema:ScholarlyArticle
2017-03
AUTHORSUdo Holtick, Marco Herling, Natali Pflug, Geothy Chakupurakal, Silke Leitzke, Dominik Wolf, Michael Hallek, Christof Scheid, Jens M. Chemnitz
ABSTRACTThe fludarabine, amsacrine, and cytarabine (FLAMSA)-reduced-intensity conditioning (RIC) protocol has been described to be effective in patients with high-risk and refractory acute myeloic leukemia (AML) undergoing allogeneic hematopoietic stem cell transplantation (aSCT). To increase safety and tolerability of the conditioning, we previously reported the feasibility to substitute the TBI component by treosulfan in elderly AML patients. We now present long-term follow-up data on patients treated with FLAMSA/treosulfan compared to the original FLAMSA/4Gy TBI protocol. We retrospectively analyzed 130 consecutive patients with high-risk or relapsed AML after aSCT following FLAMSA conditioning at our center. Fifty-eight patients were treated with FLAMSA/treosulfan due to age and/or comorbidities. Seventy-two patients were treated with FLAMSA/TBI. Median age of patients treated with FLAMSA/treosulfan was 60 years compared to 46 years in those treated with FLAMSA/TBI. The cumulative incidence of a non-relapse mortality at 4 years was 28% in FLAMSA/treosulfan patients as compared to 13% in FLAMSA/TBI. Cumulative incidence of relapse was higher in patients treated with FLAMSA/TBI (46 vs. 32%). This difference was even more prominent for patients treated in blast persistence prior to transplant (relapse incidence 70% for TBI vs. 35% for treosulfan). The overall and relapse-free survival rates at 4 years were 47 and 41%, respectively, for patients treated with FLAMSA/TBI as compared to 43 and 40% in patients treated with FLAMSA/treosulfan. These data indicate an anti-leukemic activity by FLAMSA/treosulfan especially in patients with a blast persistence prior to transplant. Older age was an independent factor for a higher non-relapse mortality. Translating FLAMSA/treosulfan to younger patients, a lower non-relapse mortality, and an improved anti-leukemic activity might add up to improved overall survival. Randomized studies are required to demonstrate an improved efficacy of treosulfan- versus TBI-based FLAMSA conditioning. More... »
PAGES479-487
http://scigraph.springernature.com/pub.10.1007/s00277-016-2887-4
DOIhttp://dx.doi.org/10.1007/s00277-016-2887-4
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1007456209
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/27909887
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Agents, Alkylating",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Busulfan",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Follow-Up Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Hematopoietic Stem Cell Transplantation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Leukemia, Myeloid, Acute",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Retrospective Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Risk Factors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Survival Rate",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Transplantation Conditioning",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Transplantation, Homologous",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Whole-Body Irradiation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Young Adult",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "University of Cologne",
"id": "https://www.grid.ac/institutes/grid.6190.e",
"name": [
"BMT Program, Department I of Internal Medicine, University of Cologne, Kerpener Stra\u00dfe 62, 50924, K\u00f6ln, Germany"
],
"type": "Organization"
},
"familyName": "Holtick",
"givenName": "Udo",
"id": "sg:person.01060152106.45",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060152106.45"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Cologne",
"id": "https://www.grid.ac/institutes/grid.6190.e",
"name": [
"BMT Program, Department I of Internal Medicine, University of Cologne, Kerpener Stra\u00dfe 62, 50924, K\u00f6ln, Germany"
],
"type": "Organization"
},
"familyName": "Herling",
"givenName": "Marco",
"id": "sg:person.01046626565.60",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046626565.60"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Cologne",
"id": "https://www.grid.ac/institutes/grid.6190.e",
"name": [
"BMT Program, Department I of Internal Medicine, University of Cologne, Kerpener Stra\u00dfe 62, 50924, K\u00f6ln, Germany"
],
"type": "Organization"
},
"familyName": "Pflug",
"givenName": "Natali",
"id": "sg:person.0775410503.46",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775410503.46"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Cologne",
"id": "https://www.grid.ac/institutes/grid.6190.e",
"name": [
"BMT Program, Department I of Internal Medicine, University of Cologne, Kerpener Stra\u00dfe 62, 50924, K\u00f6ln, Germany"
],
"type": "Organization"
},
"familyName": "Chakupurakal",
"givenName": "Geothy",
"id": "sg:person.0776253454.97",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0776253454.97"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Cologne",
"id": "https://www.grid.ac/institutes/grid.6190.e",
"name": [
"BMT Program, Department I of Internal Medicine, University of Cologne, Kerpener Stra\u00dfe 62, 50924, K\u00f6ln, Germany"
],
"type": "Organization"
},
"familyName": "Leitzke",
"givenName": "Silke",
"id": "sg:person.01167664514.20",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167664514.20"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Bonn",
"id": "https://www.grid.ac/institutes/grid.10388.32",
"name": [
"Department III of Internal Medicine, University of Bonn, Bonn, Germany"
],
"type": "Organization"
},
"familyName": "Wolf",
"givenName": "Dominik",
"id": "sg:person.014553451012.26",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014553451012.26"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Cologne",
"id": "https://www.grid.ac/institutes/grid.6190.e",
"name": [
"BMT Program, Department I of Internal Medicine, University of Cologne, Kerpener Stra\u00dfe 62, 50924, K\u00f6ln, Germany"
],
"type": "Organization"
},
"familyName": "Hallek",
"givenName": "Michael",
"id": "sg:person.01025161256.58",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025161256.58"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Cologne",
"id": "https://www.grid.ac/institutes/grid.6190.e",
"name": [
"BMT Program, Department I of Internal Medicine, University of Cologne, Kerpener Stra\u00dfe 62, 50924, K\u00f6ln, Germany"
],
"type": "Organization"
},
"familyName": "Scheid",
"givenName": "Christof",
"id": "sg:person.01312015730.26",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312015730.26"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Cologne",
"id": "https://www.grid.ac/institutes/grid.6190.e",
"name": [
"BMT Program, Department I of Internal Medicine, University of Cologne, Kerpener Stra\u00dfe 62, 50924, K\u00f6ln, Germany"
],
"type": "Organization"
},
"familyName": "Chemnitz",
"givenName": "Jens M.",
"id": "sg:person.01126003571.55",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126003571.55"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/bmt.2015.297",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1000925323",
"https://doi.org/10.1038/bmt.2015.297"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2005-10-4165",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1002613179"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00277-015-2349-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1005008575",
"https://doi.org/10.1007/s00277-015-2349-4"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1080/10428190701671051",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006880760"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1001/jama.1993.03510010063030",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1008473572"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2002-11-3615",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1008819249"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2015.62.7273",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1016119976"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2013.48.8114",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1018190408"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3324/haematol.2012.070235",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1025546715"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2009.23.3429",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026375599"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2005-05-2004",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1027035706"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/ejh.12615",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031702566"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2003-03-0855",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034662194"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.bmt.1705965",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1035841647",
"https://doi.org/10.1038/sj.bmt.1705965"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bmt.2013.185",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1036134746",
"https://doi.org/10.1038/bmt.2013.185"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00277-011-1253-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037372318",
"https://doi.org/10.1007/s00277-011-1253-9"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/moh.0b013e3283309647",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044469666"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/moh.0b013e3283309647",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044469666"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/moh.0b013e3283309647",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044469666"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2005.07.061",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044565530"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.bmt.1704784",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050128567",
"https://doi.org/10.1038/sj.bmt.1704784"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1046/j.1365-2141.2000.02196.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1056733260"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1080/10245330701214285",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1058358190"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2002.12.049",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1064203203"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1076834181",
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.1988.6.10.1562",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1079525316"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1083204471",
"type": "CreativeWork"
}
],
"datePublished": "2017-03",
"datePublishedReg": "2017-03-01",
"description": "The fludarabine, amsacrine, and cytarabine (FLAMSA)-reduced-intensity conditioning (RIC) protocol has been described to be effective in patients with high-risk and refractory acute myeloic leukemia (AML) undergoing allogeneic hematopoietic stem cell transplantation (aSCT). To increase safety and tolerability of the conditioning, we previously reported the feasibility to substitute the TBI component by treosulfan in elderly AML patients. We now present long-term follow-up data on patients treated with FLAMSA/treosulfan compared to the original FLAMSA/4Gy TBI protocol. We retrospectively analyzed 130 consecutive patients with high-risk or relapsed AML after aSCT following FLAMSA conditioning at our center. Fifty-eight patients were treated with FLAMSA/treosulfan due to age and/or comorbidities. Seventy-two patients were treated with FLAMSA/TBI. Median age of patients treated with FLAMSA/treosulfan was 60\u00a0years compared to 46\u00a0years in those treated with FLAMSA/TBI. The cumulative incidence of a non-relapse mortality at 4\u00a0years was 28% in FLAMSA/treosulfan patients as compared to 13% in FLAMSA/TBI. Cumulative incidence of relapse was higher in patients treated with FLAMSA/TBI (46 vs. 32%). This difference was even more prominent for patients treated in blast persistence prior to transplant (relapse incidence 70% for TBI vs. 35% for treosulfan). The overall and relapse-free survival rates at 4\u00a0years were 47 and 41%, respectively, for patients treated with FLAMSA/TBI as compared to 43 and 40% in patients treated with FLAMSA/treosulfan. These data indicate an anti-leukemic activity by FLAMSA/treosulfan especially in patients with a blast persistence prior to transplant. Older age was an independent factor for a higher non-relapse mortality. Translating FLAMSA/treosulfan to younger patients, a lower non-relapse mortality, and an improved anti-leukemic activity might add up to improved overall survival. Randomized studies are required to demonstrate an improved efficacy of treosulfan- versus TBI-based FLAMSA conditioning.",
"genre": "research_article",
"id": "sg:pub.10.1007/s00277-016-2887-4",
"inLanguage": [
"en"
],
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1018247",
"issn": [
"1269-3286",
"1279-8509"
],
"name": "Annals of Hematology",
"type": "Periodical"
},
{
"issueNumber": "3",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "96"
}
],
"name": "Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol substituting 4 Gy TBI with treosulfan in an elderly population with high-risk AML",
"pagination": "479-487",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"2383efb33993cdb76c2494692526325dd4575e739d3e99675078080540a7e675"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"27909887"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"9107334"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s00277-016-2887-4"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1007456209"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s00277-016-2887-4",
"https://app.dimensions.ai/details/publication/pub.1007456209"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-11T12:24",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000362_0000000362/records_87100_00000000.jsonl",
"type": "ScholarlyArticle",
"url": "https://link.springer.com/10.1007%2Fs00277-016-2887-4"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-016-2887-4'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-016-2887-4'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-016-2887-4'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-016-2887-4'
This table displays all metadata directly associated to this object as RDF triples.
279 TRIPLES
21 PREDICATES
72 URIs
39 LITERALS
27 BLANK NODES